Dr. Mohammad Dahrouj , MD, PhD
Ophthalmology โข Boston, MA
243 Charles St
Boston, MA 021143002
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Mohammad Dahrouj is listed in NPPES under Ophthalmology.
-
NPI assigned on March 31, 2015; this date does not establish years in practice.
-
Published CMS data list 5,120 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 92134 โ Imaging of retina: 2,131 service units.
- 67028 โ Injection of drug into eye: 996 service units.
- 92014 โ Established patient complete exam of visual system: 418 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 17 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 260 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Prednisolone Acetate โ 68 prescription fills, including refills.
- Ketorolac Tromethamine โ 60 prescription fills, including refills.
- Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) โ 42 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 8 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 90% of clinicians listed under Ophthalmology in Boston, MA (2024, 177 clinicians with data). Median for this group: 1,047. Middle half: 305 to 2,413.
More Medicare Part B services than 80% of clinicians listed under Ophthalmology in Massachusetts (2024, 480 clinicians with data). Median for this group: 1,836. Middle half: 621 to 3,502.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 87 in 2020 to 5,120 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
243 Charles St
Boston, MA 021143002
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 1 additional practice-address record in Dover, NH. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 1 group name: Massachusetts Eye And Ear Associates, Inc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Medical University Of South Carolina College Of Medicine
2015
What Public CMS Data Show
Ophthalmology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
954 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $531,108 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $397,608 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
402 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$8,339 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $8,538.96 across 13 records.
By nature of payment
- Consulting Fee: $6,750.00 across 1 record.
- Food and Beverage: $995.98 across 9 records.
- Travel and Lodging: $792.98 across 3 records.
Reporting-company totals
- Genentech, Inc.: $7,853.37 across 8 records.
- Alcon Vision LLC: $469.20 across 3 records.
- Neurotech Pharmaceuticals, Inc.: $216.39 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
11 years (graduated 2015)
CMS Doctors and Clinicians data list 2015 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2015
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Dahrouj has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Dahrouj as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Boston and Massachusetts
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 90% of clinicians listed under Ophthalmology in Boston, MA (2024, 177 clinicians with data). Median for this group: 1,047. Middle half: 305 to 2,413.
More Medicare Part B services than 80% of clinicians listed under Ophthalmology in Massachusetts (2024, 480 clinicians with data). Median for this group: 1,836. Middle half: 621 to 3,502.
Medicare-allowed amount
A higher Medicare-allowed amount than 85% of clinicians listed under Ophthalmology in Boston, MA (2024, 177 clinicians with data). Median for this group: $108,864. Middle half: $25,470 to $216,871.
A higher Medicare-allowed amount than 80% of clinicians listed under Ophthalmology in Massachusetts (2024, 480 clinicians with data). Median for this group: $193,068. Middle half: $60,397 to $416,557.
Paid by Medicare
A higher Medicare payment amount than 85% of clinicians listed under Ophthalmology in Boston, MA (2024, 177 clinicians with data). Median for this group: $80,468. Middle half: $19,073 to $160,958.
A higher Medicare payment amount than 80% of clinicians listed under Ophthalmology in Massachusetts (2024, 480 clinicians with data). Median for this group: $143,381. Middle half: $41,538 to $304,079.
Medicare Part D prescriptions
Fewer Part D prescriptions than 60% of clinicians listed under Ophthalmology in Boston, MA (2024, 196 clinicians with data). Median for this group: 491. Middle half: 117 to 1,271.
Fewer Part D prescriptions than 70% of clinicians listed under Ophthalmology in Massachusetts (2024, 516 clinicians with data). Median for this group: 777. Middle half: 213 to 2,065.
Part D drug cost
A lower Part D drug cost than 60% of clinicians listed under Ophthalmology in Boston, MA (2024, 196 clinicians with data). Median for this group: $25,831. Middle half: $3,169 to $133,712.
A lower Part D drug cost than 70% of clinicians listed under Ophthalmology in Massachusetts (2024, 516 clinicians with data). Median for this group: $59,749. Middle half: $7,822 to $215,537.
318 active clinicians are listed under Ophthalmology with a practice address in Boston, MA (786 in Massachusetts).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Boston
6.3% of these 318 clinicians have the CMS telehealth indicator.
60.7% of these 318 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 5785% from 87 in 2020 to 5,120 in 2024.
- 2020: 87
- 2021: 1,620
- 2022: 4,221
- 2023: 4,637
- 2024: 5,120
-
Medicare-allowed amount
Medicare-allowed amount increased 6202% from $8,428 in 2020 to $531,108 in 2024.
- 2020: $8,428
- 2021: $158,477
- 2022: $474,670
- 2023: $463,238
- 2024: $531,108
-
Paid by Medicare
Paid by Medicare increased 6860% from $5,713 in 2020 to $397,608 in 2024.
- 2020: $5,713
- 2021: $126,071
- 2022: $362,386
- 2023: $350,440
- 2024: $397,608
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 30% from 372 in 2020 to 260 in 2024.
- 2020: 372
- 2021: 245
- 2022: 200
- 2023: 200
- 2024: 260
-
30-day fills
30-day fills decreased 11% from 449 in 2020 to 402 in 2024.
- 2020: 449
- 2021: 303
- 2022: 272
- 2023: 313
- 2024: 402
-
Part D drug cost
Part D drug cost decreased 50% from $16,599 in 2020 to $8,339 in 2024.
- 2020: $16,599
- 2021: $9,772
- 2022: $5,726
- 2023: $7,007
- 2024: $8,339
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $336.03 in 2021 to $8,538.96 in 2025.
- 2021: $336.03
- 2022: $394.53
- 2023: $5,865.82
- 2024: $2,089.67
- 2025: $8,538.96
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 13 records totaling $8,538.96.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Genentech, Inc. |
Consulting Fee
Cash or cash equivalent
|
Vabysmo | General | $6,750.00 |
| Genentech, Inc. |
Travel and Lodging
In-kind items and services
|
Vabysmo | General | $457.70 |
| Genentech, Inc. |
Travel and Lodging
In-kind items and services
|
Vabysmo | General | $292.67 |
| Alcon Vision LLC |
Food and Beverage
In-kind items and services
|
UNITY | General | $179.60 |
| Neurotech Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
โ | General | $155.42 |
| Alcon Vision LLC |
Food and Beverage
In-kind items and services
|
Constellation | General | $154.38 |
| Alcon Vision LLC |
Food and Beverage
In-kind items and services
|
UNITY | General | $135.22 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Vabysmo | General | $111.82 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Vabysmo | General | $89.98 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Vabysmo | General | $74.99 |
| Neurotech Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
โ | General | $60.97 |
| Genentech, Inc. |
Travel and Lodging
In-kind items and services
|
Vabysmo | General | $42.61 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Vabysmo | General | $33.60 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2018โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2019โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
92134
Imaging of retina
|
2,131 | 814 | $124.34 | $28.42 |
|
67028
Injection of drug into eye
|
996 | 252 | $547.37 | $105.15 |
|
92014
Established patient complete exam of visual system
|
418 | 378 | $351.61 | $85.56 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
330 | 204 | $295.19 | $72.51 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
318 | 211 | $431.55 | $106.01 |
|
J0178
Injection, aflibercept, 1 mg
|
268 | 33 | $2802.61 | $820.05 |
|
92134
Imaging of retina
|
250 | 124 | $113.00 | $26.18 |
|
67028
Injection of drug into eye
|
110 | 31 | $502.04 | $100.79 |
|
92014
Established patient complete exam of visual system
|
70 | 66 | $322.29 | $79.74 |
|
92004
New patient complete exam of visual system
|
63 | 63 | $468.33 | $112.71 |
|
76512
2d ultrasound scan of eye tissue and structures
|
40 | 35 | $163.80 | $33.81 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
38 | 28 | $410.76 | $100.12 |
|
76512
2d ultrasound scan of eye tissue and structures
|
25 | 21 | $216.00 | $37.50 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
24 | 17 | $277.88 | $69.15 |
|
92201
Extended exam of the back part of the eye with retinal drawing
|
15 | 14 | $96.47 | $24.02 |
|
92250
Photography of the retina
|
13 | 12 | $73.23 | $21.76 |
|
67108
Repair of detached retina with drainage and removal of eye fluid between lens and retina
|
11 | 11 | $5109.64 | $1266.12 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Prednisolone Acetate | Prednisolone Acetate | 68 | 2,717 | $3,235.38 | 37 |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 60 | 2,622 | $1,117.83 | 31 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 42 | 2,433 | $623.82 | 15 |
| Latanoprost | Latanoprost | 27 | 1,210 | $274.32 | 13 |
| Dorzolamide Hcl | Dorzolamide Hcl | 20 | 1,030 | $351.40 | โ |
| Erythromycin | Erythromycin Base | 20 | 311 | $277.83 | โ |
| Brimonidine Tartrate | Brimonidine Tartrate | 12 | 630 | $111.08 | โ |
| Bromfenac Sodium | Bromfenac Sodium | 11 | 373 | $2,347.80 | โ |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2022-10-18NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OPHTHALMOLOGY
I20190715001716
MA
3375863665
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Massachusetts Eye And Ear Associates, Inc
1 Randall Sq, Providence, RI 029042773
Phone: 4014534600
Massachusetts Eye And Ear Associates, Inc
243 Charles St, Boston, MA 021143002
Phone: 6175237900
Secondary Practice Locations
789 Central Ave
Dover, NH 038202526
Phone: 6037402263
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Additional practice office at 789 Central Ave, Dover, NH 038202526
Ophthalmology (license number reported to NPPES: NH 22949)
Registered at 243 CHARLES ST, BOSTON, MA 021143002 (Tel: 6175733288)
Registered at 243 CHARLES ST, BOSTON, MA 021143002 (Tel: 6175733288)
Ophthalmology (license number reported to NPPES: MA 278738)
NPI status registered as active in NPPES database
Registered at 243 CHARLES ST, 3RD FLOOR OPHTHALMOLOGY EDUCATION, BOSTON, MA 021143096 (Tel: 6175237900)
Registered at 243 CHARLES ST, 3RD FLOOR OPHTHALMOLOGY EDUCATION, BOSTON, MA 021143096 (Tel: 6175237900)
Recorded as MOHAMMAD DAHROUJ, MD., PHD.
Student in an Organized Health Care Education/Training Program
NPI status registered as active in NPPES database
Registered at 1633 N CAPITOL AVE, METHODIST MEDICAL TOWER, STE 640, INDIANAPOLIS, IN 462021261 (Tel: 3179628881)
Registered at 1633 N CAPITOL AVE, METHODIST MEDICAL TOWER, STE 640, INDIANAPOLIS, IN 462021261 (Tel: 3179628881)
Recorded as MOHAMMAD DAHROUJ, MD., PHD.
Student in an Organized Health Care Education/Training Program
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Ophthalmology Specialists in Boston
- Heba Mahjoub
- Frances Wu
- Dr. Elizabeth Rossin, MD, PhD
- Dr. Nayan Sanjiv, MD
- Dr. Sandra Cremers, MD
- Dr. Johanna Seddon, MD
Mailing Address
243 Charles St
Boston, MA 021143002
Phone: 6175733288